ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 177 filers reported holding ARGENX SE in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,732,131 | +18.8% | 5,558 | -5.8% | 0.85% | +22.7% |
Q2 2023 | $2,298,937 | -4.7% | 5,900 | -8.9% | 0.69% | -5.2% |
Q1 2023 | $2,411,641 | -7.1% | 6,474 | -5.5% | 0.73% | -3.4% |
Q4 2022 | $2,595,364 | -72.6% | 6,851 | -80.1% | 0.76% | +582.0% |
Q1 2021 | $9,479,000 | +1.0% | 34,421 | +7.8% | 0.11% | -92.0% |
Q4 2020 | $9,389,000 | +9.9% | 31,925 | -1.9% | 1.39% | -10.1% |
Q3 2020 | $8,547,000 | +10.2% | 32,558 | -4.8% | 1.54% | -2.7% |
Q2 2020 | $7,755,000 | +58.4% | 34,212 | -8.0% | 1.58% | -14.8% |
Q1 2020 | $4,896,000 | -26.4% | 37,170 | -10.3% | 1.86% | -15.4% |
Q4 2019 | $6,648,000 | +35.0% | 41,416 | -4.1% | 2.20% | +77.2% |
Q3 2019 | $4,924,000 | -20.8% | 43,206 | -1.6% | 1.24% | -17.8% |
Q2 2019 | $6,217,000 | +6.1% | 43,910 | -6.5% | 1.51% | +6.4% |
Q1 2019 | $5,861,000 | +30.5% | 46,946 | +0.4% | 1.42% | +5.6% |
Q4 2018 | $4,490,000 | -5.8% | 46,737 | -25.7% | 1.34% | +54.4% |
Q3 2018 | $4,767,000 | -39.4% | 62,861 | -33.3% | 0.87% | -24.8% |
Q2 2018 | $7,869,000 | – | 94,178 | – | 1.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |